This information was published on 2026-03-06T10:50:07 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2626793 (IR 1901847) |
| (220) |
16 Jan 2026
|
| (300) |
US, 05 Sep 2025, 99377590
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of oncological and immune system related diseases and disorders. Class 42 Pharmaceutical research and development; drug discovery services; providing information about medical and scientific research. Class 44 Providing medical information; providing health information. |
| (540) | RASONQUE |
| (550) | Word |
| (730) |
Revolution Medicines, Inc.
|
Find out more about publications on the About page.